Get 20% Off All Market Studies With Code ONLINE20 – Anticipate Tariff Impacts, Market Disruptors, and Long-Term Growth Trends
What Is the Forecasted Market Size of the Nausea Medicine Market by 2029?
The nausea medicine market size has grown strongly in recent years. It will grow from $3.02 billion in 2024 to $3.22 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increased chemotherapy cases, pregnancy-related nausea (NVP) awareness, surgical procedure growth, a rise in motion sickness awareness, chronic gastrointestinal disorder prevalence, and expansion in pediatric formulations.
The nausea medicine market size is expected to see strong growth in the next few years. It will grow to $4.21 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to rising cancer treatment penetration, regulatory push for safer ingredients, expansion of telehealth & e-prescriptions, expansion of minimally invasive surgeries, and hospital infrastructure expansion. Major trends in the forecast period include the integration of digital health solutions, the development of targeted therapies, the shift towards personalized medicine, the adoption of transdermal patches for treatment, and advancements in drug formulations.
Claim your free report sample now:
What Are the Major Drivers Influencing the Nausea Medicine Market?
The rising consumption of unhealthy diets is expected to propel the growth of the nausea medicine market going forward. An unhealthy diet is consuming excessive amounts of processed foods, sugars, unhealthy fats, and salt while lacking essential nutrients such as vitamins, minerals, and fiber. The increase in the consumption of unhealthy diets is mainly due to the convenience of processed and fast foods, which are cheaper and easier to access than healthier options. Rising consumption of unhealthy diets leads to gastrointestinal discomfort, indigestion, acid reflux, and nausea. Nausea medicine, such as antiemetics, helps relieve nausea by targeting the underlying causes, such as motion sickness, gastrointestinal issues, or side effects from medications. These medicines work by blocking the signals in the brain that trigger the sensation of nausea or by soothing the stomach, helping to reduce the urge to vomit and providing relief. For instance, in April 2025, according to the American Journal of Preventive Medicine, a US-based government organization, each year, the number of deaths caused by ultra-processed foods in the United States is over 124,000. Therefore, rising unhealthy diets are driving the growth of the nausea medicine market.
Which Are the Leading Segments in the Nausea Medicine Market by Revenue?
The nausea medicine market covered in this report is segmented –
1) By Type: Antagonists, Antagonists, Canabinoids, Other Types
2) By Indication: Oncology, Gastroesophageal Reflux Disease, Motion Sickness and Seasickness, Other Indications
3) By Route of Administration: Oral, Injectable, Transdermal, Rectal, Other Route of Administrations
4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Other Distribution Channels
5) By End User: Hospitals, Homecare settings, Ambulatory Surgical centres, Long-term Care Facilities, Individual Consumers
Subsegments:
1) By Antagonists: Serotonin Antagonists, Neurokinin-1 (NK1) Receptor Antagonists, Dopamine Antagonists
2) By Antihistamines: H1 Antihistamines, H2 Antihistamines
3) By Cannabinoids: THC (Tetrahydrocannabinol), CBD (Cannabidiol)
4) By Other Types: Corticosteroids, Benzodiazepines, Ginger-Based Medications
What Are the Significant Trends in the Nausea Medicine Market Across Regions?
Major companies operating in the nausea medicine market are focusing on developing innovative solutions, such as chemotherapy-induced nausea medication, to improve patient outcomes and address treatment-resistant cases. Chemotherapy-induced nausea medication refers to drugs specifically designed to prevent or relieve nausea and vomiting caused by cancer chemotherapy, often by targeting serotonin or neurokinin receptors in the brain. For instance, in January 2023, Glenmark Pharmaceuticals, an India-based pharmaceutical company, introduced AKYNZEO I.V., a ready-to-dilute intravenous injection combining fosnetupitant and palonosetron, to prevent chemotherapy-induced nausea and vomiting (CINV). This single-dose intravenous medication combines fosnetupitant and palonosetron, offering protection against both acute and delayed phases of CINV. This single 30-minute infusion effectively covers both acute and delayed phases of CINV, simplifying treatment by reducing the need for multiple antiemetic drugs and improving patient compliance.
Who Are the Leading Players in the Nausea Medicine Market?
Major companies operating in the nausea medicine market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer Aktiengesellschaft, Merck & Co. Inc., Sanofi S.A., Novartis AG, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Helsinn Healthcare SA, Mylan N.V., Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, Zydus Lifesciences Limited, Amneal Pharmaceuticals Inc.
Get the full nausea medicine market report here:
What Are the Opportunities and Challenges for Nausea Medicine Market Across Regions?
North America was the largest region in the nausea medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nausea medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment